Press release article from our research archive:
|
|
Peninsula Pharmaceuticals, Inc. Announces Presentation of New Data On Doripenem (S-4661) at ICAAC; - Eight Posters Presented at the 43d Annual Interscience Conference On Antimicrobial Agents and Chemotherapy -.
- Article from:
-
PR Newswire
- Article date:
-
September 15, 2003
|
Copyright informationCOPYRIGHT 2003 PR Newswire Association, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
ALAMEDA, Calif., Sept. 15 /PRNewswire/ -- Peninsula Pharmaceuticals, Inc. today announced that eight posters are being presented on doripenem (also known as S-4661) at the 43d Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) being held in Chicago this week.
"Doripenem has been found to be safe and effective in numerous Japanese studies, and the data presented at ICAAC are the first steps in demonstrating the same in western populations," said Matthew A. Wikler, M.D. FIDSA, Chief Medical Officer and Executive Vice President at Peninsula. "The results of the studies presented in the eight posters at ICAAC better define the antimicrobial ...
Related newspaper, magazine, and journal articles:
|
Peninsula Pharmaceuticals, Inc. Begins Phase III Clinical Trial of...
PR Newswire;
June 10, 2004 ;
610 words
......10 /PRNewswire/ -- Peninsula Pharmaceuticals, Inc., a privately-he...product candidate, doripenem for injection, in...pleased to be moving doripenem forward in another...We believe that doripenem will prove to be...generated to date with doripenem and are committed...numerous ...
|
|
|
Peninsula Pharmaceuticals, Inc. Begins Phase III Clinical Trials With...
PR Newswire;
March 30, 2004 ;
660 words
......30 /PRNewswire/ -- Peninsula Pharmaceuticals, Inc., a privately-he...its lead product, doripenem (also known as S...well documented. Doripenem has demonstrated...plan for the use of doripenem in the treatment...clinical trials of doripenem for the treatment...in the hospital. ...
|
|
|
Peninsula Pharmaceuticals, Inc. Begins Phase I Clinical Trial of Inhaled...
PR Newswire;
January 15, 2004 ;
700+ words
......15 /PRNewswire/ -- Peninsula Pharmaceuticals, Inc., a privately-he...product candidate, doripenem, a broad-spectrum...early 30s. About Doripenem Doripenem is a new member of...Shionogi & Co. Ltd., doripenem has demonstrated...inhaled formulations of doripenem for ...
|
|
|
Peninsula Pharmaceuticals, Inc. Begins Second Phase III Clinical Trial of...
PR Newswire;
April 15, 2004 ;
674 words
......15 /PRNewswire/ -- Peninsula Pharmaceuticals, Inc., a privately-he...product candidate, doripenem (also known as S...efficacy of intravenous doripenem in patients with...We believe that doripenem may provide a valuable...continues to increase. Doripenem has the ...
|
|
|
Peninsula Pharmaceuticals, Inc. Begins Phase III Clinical Trial with...
PR Newswire;
December 23, 2003 ;
482 words
......23 /PRNewswire/ -- Peninsula Pharmaceuticals, Inc., a privately-he...its lead product, doripenem (also known as S...hospital-based infections. Doripenem may prove to be an...the inventor of doripenem, has filed a New Drug Application for doripenem in Japan with the...and Welfare. ...
|
|
|
Peninsula Pharmaceuticals, Inc. Announces Early Completion of Phase 2...
PR Newswire;
September 3, 2003 ;
576 words
......3 /PRNewswire/ -- Peninsula Pharmaceuticals, Inc. announced today...clinical trial of doripenem (also known as S...drug application for doripenem in North America...the inventor of doripenem, expects to file...pharmacokinetic (PK) profile of doripenem with a number of...in Chicago. ...
|
|
|
Peninsula Pharmaceuticals, Inc. Begins Final Phase III Clinical Trial of...
PR Newswire;
July 13, 2004 ;
700+ words
......13 /PRNewswire/ -- Peninsula Pharmaceuticals, Inc., a privately-he...product candidate, doripenem. Doripenem, a broad-spectr...prolonged infusion of doripenem in patients with...Pseudomonas aeruginosa. Doripenem has demonstrated...fragilis. In addition, doripenem is ...
|
|
|
FDA Grants Peninsula Pharmaceuticals Fast Track Designation for Doripenem.
PR Newswire;
October 27, 2004 ;
700+ words
......27 /PRNewswire/ -- Peninsula Pharmaceuticals, Inc., a privately-he...Track designation for Doripenem for the treatment...the development of Doripenem as rapidly as possible...the development of Doripenem and PPI-0903, our...candidate. About Doripenem Doripenem is a new member ...
|
|
|
Peninsula Pharmaceuticals Secures $22.1 Million in Series B Financing.
PR Newswire;
October 28, 2002 ;
396 words
......Commercialization Plan of Lead Product Peninsula Pharmaceuticals Inc., a pharmaceutical development...and Sears Capital Management. Peninsula Pharmaceuticals has a highly qualified commercial...group looks forward to supporting Peninsula Pharmaceuticals' mission as it continues to ...
|
|
Doripenem (Doribax): the newest addition to the carbapenems.(Pharmacology...
Baylor University Medical Center Proceedings;
July 1, 2008 ;
700+ words
......antimicrobials structurally related to penicillin. Doripenem, the newest agent in this class, was...aeruginosa isolates may remain sensitive to doripenem, although the clinical relevance of that...in abstract form to date, have found doripenem to be similar to comparator agents. The...
|
See all results.
Or, try our
Advanced Search.
|